Drug Discovery

#Drug design #Drug development #Webinar

Webinar: How can a structure-based strategy fast-track drug delivery?

Join DDW and Curia on 14 October for a webinar on how X-ray crystallography can accelerate the drug design process. The first challenge in drug discovery is selecting a biological target and validating it as a ‘druggable’ binding site. The key to this is identifying several… Read More

#News

#Biotech #CDMO #Collaboration #Drug development

How speed and clarity decide biotech’s winners 

Dr Thomas Meins, General Manager of WuXi AppTec’s subsidiary Crelux in Munich, Germany discusses how agile collaboration helps innovators adapt and succeed. Every biotech project begins with a vision, an idea with the potential to turn science into impact. But a vision alone is not enough. Turning that idea… Read More

#Exclusive Content

#Alys Pharmaceuticals #Atopic dermatitis #Biotechnology #Cold Urticaria #Dermatology #Drug discovery #Mastocytosis #Seed funding #Systemic mastocytosis

New podcast: First-in-class mechanisms for the next wave of dermatology innovation

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Thibaud Portal, Founder… Read More

#News

Vaccine
#Clinical trials #Drug development #Drug discovery #Vaccines

Developing a new targeted vaccine for Pneumococcal disease in Malawi 

Earlier this year, the Infection Innovation Consortium: iiCON and partners launched the first human challenge trial for a new vaccine for pneumococcal disease – marking a key milestone in a collaborative global project that is offering new hope in the fight against the disease. Professor Stephen Gordon, Director of Experimental… Read More

#Exclusive Content

Business financing
#Artificial intelligence (AI) #Drug development #Drug discovery #Financing

Tres Alchemix closes $4.4 million financing round

AI-driven biotechnology company Tres Alchemix has closed its $4.4 million Series A financing round, the company has announced.  New funding will be used to accelerate the development of Tres Alchemix’s predictive AI platform and support the opening of a new laboratory at The Oxford Science Park, a… Read More

#Business & Investment #News #Start-up Zone

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #Personalised medicine #Webinar

Webinar: Explore strategies to streamline biomarker discovery

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. Taking place on 23 October at 4pm BST, this webinar, hosted by DDW and supported by Danaher Life… Read More

Webinar date:
Supported by Danaher
#News

#Biopharmaceuticals #Drug discovery #High throughput screening #Sartorius

Advancing global health through innovation

This paid-for advertorial from Sartorius appeared in DDW Volume 26 – Issue 4, Fall 2025 The global health landscape is complex and constantly shifting, presenting multifaceted challenges for the pharmaceutical industry. To keep… Read More

#Exclusive Content

London skyline
#DDW Turning Science into Business Symposium #Drug discovery #Events #The Francis Crick Institute

Chas Bountra, Oxford Uni, confirmed to speak at DDW Symposium

The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November. DDW is delighted to welcome Chas Bountra Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University to the expert speaker line-up. Bountra… Read More

#News

#Artificial intelligence (AI) #Biologics #Drug discovery

Enabling AI in chemistry and biologics discovery

This paid-for advertorial from CDD Vault appeared in DDW Volume 26 – Issue 4, Fall 2025   CDD Vault outlines what to look for in an SDMP across chemistry and biologics using examples from CDD Vault and other leading platforms. Read More

#Exclusive Content

#Cancer research #Drug discovery

Ebook: The impact of ADCs on drug discovery

Antibody-drug conjugates (ADCs) offer a targeted approach to cancer treatment, combining the specificity of antibodies with the potency of cytotoxic drugs, and have shown promise in improving patient outcomes. This eBook, sponsored by Abzena, explores the latest developments in the ADC field and the opportunities presented by next generation bioconjugates. Read More

#DDW eBooks

#Assays #bit bio #Disease modelling #Drug discovery #iPSC #iPSC-derived cells

Listicle: Get the best out of human iPSC derived cells in your assays

Watch this DDW listicle, 5 ways to get the best out of human iPSC-derived cells in your assays from bit.bio, for free now. Transitioning to human iPSC-derived cells can open powerful opportunities for drug discovery, neuroscience, and disease modelling, but success depends on how you handle and culture them. Read More

#News

Synapses in the brain
#Drug discovery #eBook #Regenerative Medicine #Rejuvenation therapies

eBook: Unlocking the power of regenerative medicine

The term “regenerative medicine” is used to refer to methods to replace or regenerate human cells, tissues or organs to restore or establish normal function. This includes cell therapies, tissue engineering, gene therapy and biomedical engineering techniques, as well as more traditional treatments involving pharmaceuticals, biologics and devices. Read More

#News

#Cell Science #Drug discovery #Therapeutic Antibodies

Breaking barriers in cell and gene therapy ed led webinar Sept 2025

Hosted by Drug Discovery World and sponsored by Oxford Nanopore Technologies, this webinar explores developments in CGT drug discovery and development. You will hear from Brian Culley, CEO of Lineage Cell Therapeutics, Will Decker, CSO of Diakonos Oncology, and John Maher, Scientific Founder and CSO of Leucid Bio. In… Read More

#Webinars

Vaccine
#Drug development #Drug discovery #Immunology / Virology & Vaccines #mRNA-based vaccines

The expanding market of vaccines  

By Stephen Adams, Associate Director, Optimum Strategic Communications  To say that vaccines and vaccine makers have been on a popularity rollercoaster in recent years is an understatement. Five years ago, with the world’s biotechs and pharma firms engaged in a high-stakes race to develop the first… Read More

#Exclusive Content

#Drug design #Drug development #Webinar

Don’t miss this webinar on breakthroughs in drug design

Don’t miss this webinar on how X-ray crystallography can accelerate the drug design process, hosted by DDW and supported by Curia. The first challenge in drug discovery is selecting a biological target and validating it as a ‘druggable’ binding site. The key to this is identifying several potent compounds that… Read More

#News